Unique ID issued by UMIN | UMIN000000838 |
---|---|
Receipt number | R000001003 |
Scientific Title | Multi-centric randomized open-label comparative study for influence of bisphosphonate on fracture healing in patients with spinal compression fractures or femoral neck fractures |
Date of disclosure of the study information | 2007/10/01 |
Last modified on | 2012/10/01 19:12:26 |
Multi-centric randomized open-label comparative study for influence of bisphosphonate on fracture healing in patients with spinal compression fractures or femoral neck fractures
Influence of bisphosphonate on spinal compression fractures or femoral neck fractures
Multi-centric randomized open-label comparative study for influence of bisphosphonate on fracture healing in patients with spinal compression fractures or femoral neck fractures
Influence of bisphosphonate on spinal compression fractures or femoral neck fractures
Japan |
Osteoporotic spinal compression fractures and femoral neck fractures
Orthopedics |
Others
NO
To investigate the difference of the influence of sodium risedronate hydrate on fracture healing in patients with spinal compression fracture or femoral neck fracture depending on the starting point of the medication.
Safety,Efficacy
Fracture healing is assessed with X ray film and computed tomograhy, and QOL is assessed with questionnaires.
Bone mineral density, visual analogue scale and bone markers are measured.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Uncontrolled
NO
NO
Institution is not considered as adjustment factor.
NO
Central registration
2
Treatment
Medicine |
Sodium risedronate hydrate was given from 1 week after injury or surgery in group A.
Sodium risedronate hydrate was given from 3 months after injury or surgery in group B.
65 | years-old | <= |
90 | years-old | > |
Male and Female
Inclusion criteria are primary osteoporosis patients with the age of 65 to 90 years old, osteoporotic spinal compression fractures, and osteoporotic femoral neck fractures.
Exclusion criteria are patients treated with bisphosphonate within 3 months, fractures resulted from high energy trauma, patients contraindicant to bisphosphonate, and patients judged inadequate to include this study by doctors.
100
1st name | |
Middle name | |
Last name | Satoru Ozeki |
Dokkyo Medical University Koshigaya Hospital
Department of Orthopaedic Surgery
2-1-50 Minami-Koshigaya, Koshigaya, Saitama, Japan
048-965-1111
1st name | |
Middle name | |
Last name | Takahiro Iida |
Dokkyo Medical University Koshigaya Hospital
Department of Orthopaedic Surgery
2-1-50 Minami-Koshigaya, Koshigaya, Saitama, Japan
048-965-1111
takiida@dokkyomed.ac.jp
Department of Orthopaedic Surgery, Dokkyo Medical University Koshigaya Hospital
Department of Orthopaedic Surgery, Dokkyo Medical University Koshigaya Hospital
Self funding
NO
2007 | Year | 10 | Month | 01 | Day |
Unpublished
Completed
2007 | Year | 09 | Month | 18 | Day |
2007 | Year | 10 | Month | 01 | Day |
2012 | Year | 04 | Month | 01 | Day |
2012 | Year | 04 | Month | 01 | Day |
2012 | Year | 04 | Month | 01 | Day |
2012 | Year | 09 | Month | 01 | Day |
2007 | Year | 09 | Month | 30 | Day |
2012 | Year | 10 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001003